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Comments regarding ‘Total Endovascular
Debranching of the Aortic Arch’R. Milner*Loyola University Medical Center, Vascular Surgery, 2160 South First Avenue, Maywood, Illinois 60153, United StatesEndovascular Aneurysm Repair (EVAR) was successfully
reported by Dr. Juan Parodi in the early 1990’s. His initial
report of this monumental change in the management of
aneurysm disease has allowed for the continued evolution of
endovascular therapyfor theaorta.Dr. Yoshidaandcolleagues
report two difficult cases that demonstrate this continued
evolution in endovascular therapies for aneurysmal disease.
EVAR and TEVAR have been limited in successfully
treating the aortic arch and visceral segment of the aorta
due to the natural branching of the aorta. In light of the
limits of current technology, surgical debranching proce-
dures have been utilized to expand our ability to treat
complex aneurysmal disease of the aortic arch and
abdominal aorta. But, these procedures are fraught with
a high morbidity and mortality rate.
Several reports have highlighted the value of endovas-
cular debranching of the aorta to minimize the morbidity of
surgical debranching. Yoshida et al. report a novel technique
that treats complex aneurysmal disease of the aortic arch.
They present two cases in high-risk patients that were
managed in a total endovascular fashion. They utilized
a hybrid approach with exposure of the femoral, common
carotid, and axillary arteries. They placed 12 Fr sheaths into
the common carotid arteries and axillary arteries. In addition
to placing a thoracic endograft, they placed a combination
Viabahn stents (WL Gore and Associates, Flagstaff, AZ) that
varied from 10 to 15 cm in length and were placed as proxi-
mally as the sinotubular junction with care taken to avoid
coverage of the coronary arteries. The first patient was
treatedwith branches into the innominate artery and the leftDOI of original article: 10.1016/j.ejvs.2011.06.054.
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occurred during TEVAR. In addition, a left carotid-subclavian
artery had already been placed and this vessel did not need
an endovascular branch. The second patient had all four arch
vessels treated at the time of TEVAR. The authors report
successful aneurysm exclusion in both patients. In addition,
they show 10-month follow-up in one patient and 17-month
follow-up in the second patient that demonstrates aneurysm
exclusion and no stent fractures.
I am impressed with the initial technical success and mid-
term results in these two patients. The total endovascular
aortic arch debranching technique will allow us to treat high-
risk patients in a lower riskway. But, I add awordof caution to
this promising technique. I believe that long-term follow-up is
exceptionally important in light of the interactions of endo-
vascular branches, a thoracic endograft, the aortic arch, and
every variation in systolic and diastolic pressure. An occluded
renal artery branch can lead to renal insufficiency requiring
renal replacement therapy. But, it may only lead to an
elevation in the creatinine level and no other significant
medical consequences. An occlusion of an arch vessel can
cause a significant cerebrovascular accident with significant
consequences to the patient. Therefore, care must be taken
before we frequently place covered stent grafts into the
dynamic forces of the aortic arch. These technologies are not
necessarily designed to handle these stresses and have not
been tested in thishigh-flow,high-stress environment. Iwould
like to congratulate the authors on their success with this
approach,but I look forwardtoseeing the long-termdurability
of the stentestent and archestent interactions.d by Elsevier Ltd. All rights reserved.
